NerveSolutions Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

NerveSolutions General Information


Developer of a medical device designed to prevent development of neuroma after amputation or nerve injury. The company's bioengineered device NervLok, prevents the cut end of the nerve from forming a painful neuroma when placed on the ends of nerves cut due to amputation, enabling surgeons to provide an optimal treatment for patients with peripheral nerve injuries and help them regain function with a bioengineered nerve.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
  • TX
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NerveSolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 23-May-2017 Completed Startup
To view NerveSolutions’s complete valuation and funding history, request access »

NerveSolutions Executive Team (2)

Name Title Board Seat Contact Info
Mario Romero-Ortega Ph.D Co-Founder & Chief Scientific Officer
Rafael Granja-Vazquez Co-Founder & Medical Advisor
To view NerveSolutions’s complete executive team members history, request access »

NerveSolutions Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MassChallenge Accelerator/Incubator 000 0000 000000 0
To view NerveSolutions’s complete investors history, request access »